世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
World Journal of Integrated Traditional and Western Medicine
2015年
8期
1139-1142
,共4页
加味黄芪竹叶汤%2 型糖尿病%胰岛 β 细胞功能%胰岛素
加味黃芪竹葉湯%2 型糖尿病%胰島 β 細胞功能%胰島素
가미황기죽협탕%2 형당뇨병%이도 β 세포공능%이도소
Modified Huangqizhuye decoction%Type 2 diabetes%Islet β - cell%Insulin
目的:观察加味黄芪竹叶汤治疗2型糖尿病气阴两虚证的临床疗效。方法采用随机、平行、对照研究的方法,将符合纳入标准的60例2型糖尿病患者随机分为2组,治疗组除维持原基础治疗外加用加味黄芪竹叶汤,对照组维持原糖尿病的基础治疗,疗程共8周。观察项目包括中医证候评分,空腹及餐后2 h 血糖、C 肽、胰岛素水平,糖化血红蛋白,糖化白蛋白,胰岛素抵抗指数(HO-MA - IR)及胰岛细胞功能指数(HOMA - B)等疗效性指标和安全性指标(肝肾功能、血常规、尿常规、心电图)。结果治疗组的中医证候评分下降幅度明显大于对照组,两组比较,差异有统计学意义( P﹤0.05),治疗组总有效率96.67%,对照组总有效率为36.67%;治疗组治疗后 FBG、PBG、HBA1C、GA均较治疗前下降(P ﹤0.05),且 FBG、HBA1C、GA 下降幅度优于对照组,两组比较,差异有统计学意义(P ﹤0.05),治疗组的空腹胰岛素、空腹 C 肽及餐后 C 肽水平较治疗前上升(P ﹤0.05),而治疗后的HOMA - IR 较治疗前下降、HOMA - B 较治疗前上升(P ﹤0.05),且治疗组治疗后 HOMA - B 的上升幅度大于对照组,两组比较,差异有统计学意义(P ﹤0.05)。结论加味黄芪竹叶汤干预2型糖尿病气阴两虚证疗效确切,能降低血糖,改善胰岛β细胞功能及胰岛素抵抗。
目的:觀察加味黃芪竹葉湯治療2型糖尿病氣陰兩虛證的臨床療效。方法採用隨機、平行、對照研究的方法,將符閤納入標準的60例2型糖尿病患者隨機分為2組,治療組除維持原基礎治療外加用加味黃芪竹葉湯,對照組維持原糖尿病的基礎治療,療程共8週。觀察項目包括中醫證候評分,空腹及餐後2 h 血糖、C 肽、胰島素水平,糖化血紅蛋白,糖化白蛋白,胰島素牴抗指數(HO-MA - IR)及胰島細胞功能指數(HOMA - B)等療效性指標和安全性指標(肝腎功能、血常規、尿常規、心電圖)。結果治療組的中醫證候評分下降幅度明顯大于對照組,兩組比較,差異有統計學意義( P﹤0.05),治療組總有效率96.67%,對照組總有效率為36.67%;治療組治療後 FBG、PBG、HBA1C、GA均較治療前下降(P ﹤0.05),且 FBG、HBA1C、GA 下降幅度優于對照組,兩組比較,差異有統計學意義(P ﹤0.05),治療組的空腹胰島素、空腹 C 肽及餐後 C 肽水平較治療前上升(P ﹤0.05),而治療後的HOMA - IR 較治療前下降、HOMA - B 較治療前上升(P ﹤0.05),且治療組治療後 HOMA - B 的上升幅度大于對照組,兩組比較,差異有統計學意義(P ﹤0.05)。結論加味黃芪竹葉湯榦預2型糖尿病氣陰兩虛證療效確切,能降低血糖,改善胰島β細胞功能及胰島素牴抗。
목적:관찰가미황기죽협탕치료2형당뇨병기음량허증적림상료효。방법채용수궤、평행、대조연구적방법,장부합납입표준적60례2형당뇨병환자수궤분위2조,치료조제유지원기출치료외가용가미황기죽협탕,대조조유지원당뇨병적기출치료,료정공8주。관찰항목포괄중의증후평분,공복급찬후2 h 혈당、C 태、이도소수평,당화혈홍단백,당화백단백,이도소저항지수(HO-MA - IR)급이도세포공능지수(HOMA - B)등료효성지표화안전성지표(간신공능、혈상규、뇨상규、심전도)。결과치료조적중의증후평분하강폭도명현대우대조조,량조비교,차이유통계학의의( P﹤0.05),치료조총유효솔96.67%,대조조총유효솔위36.67%;치료조치료후 FBG、PBG、HBA1C、GA균교치료전하강(P ﹤0.05),차 FBG、HBA1C、GA 하강폭도우우대조조,량조비교,차이유통계학의의(P ﹤0.05),치료조적공복이도소、공복 C 태급찬후 C 태수평교치료전상승(P ﹤0.05),이치료후적HOMA - IR 교치료전하강、HOMA - B 교치료전상승(P ﹤0.05),차치료조치료후 HOMA - B 적상승폭도대우대조조,량조비교,차이유통계학의의(P ﹤0.05)。결론가미황기죽협탕간예2형당뇨병기음량허증료효학절,능강저혈당,개선이도β세포공능급이도소저항。
Objective To observe the clinical efficacy on treatment of Qi and Yin deficiency in Type 2 diabetes with modified Huangqizhuye decoction. Methods A randomized,parallel and control study was conducted. Sixty Type 2 Diabetes patients who were in accordance with the inclusive criteria were ran-domized into two groups. Patients in treatment group received modified Huangqizhuye decoction and original basic treatment,and control group applied only original basic treatment. The treatment lasted 8 weeks. Items include effect indicators(TCM syndrome score,FBG,PBG,FINS,2h - INS,Fasting C - peptide,Postprandial C - peptide,HbA1C,GA,HOMA - IR and HOMA - B)and safety indicators(liver and kidney function,blood routine,routine urine,electrocar diography)were observed. Results The TCM syndrome total integral drop in treatment group was significantly greater than the control group( P ﹤ 0. 05). The total effective rate was 36. 67% in control group and 96. 67% in treatment group. FBG,PBG,HBA1C,GA and HOMA - IR dropped in treatment group(P ﹤ 0. 05),and FBG,HBA1C,GA dropped significantly greater than the control group(P﹤ 0. 05). Levels of FINS,Fasting C - peptide,Postprandial C - peptide and HOMA - B raised in treatment group(P ﹤ 0. 05),and HOMA - B raised significantly greater than the control group(P ﹤ 0. 05). Conclusion Modified Huangqizhuye decoction can effectively improve symptoms of Qi and Yin deficiency in Type 2 Dia-betes,lower blood glucose,improve islet β - cell function and relieve insulin resistance.